GynecologyGynecology2079-56962079-5831Consilium Medicum7102010.26442/20795696.2021.2.200775Research ArticleCervical cancer: monitoring of the main indicators characterizing this pathology in Khabarovsk Krai (2009–2019)PestrikovaTatyana Yu.<p>D. Sci. (Med.), Prof., Far Eastern State Medical University</p>typ50@rambler.ruhttps://orcid.org/0000-0003-0219-3400IsmaylovaAinur F.<p>Graduate Student, Far Eastern State Medical University</p>dr.aynur@mail.ruhttps://orcid.org/0000-0002-0253-604XKiselevSergey N.<p>D. Sci. (Med.), Prof., Far Eastern State Medical University</p>serkiss@rambler.ruhttps://orcid.org/0000-0003-2047-9824Far Eastern State Medical University150420212321551602605202126052021Copyright © 2021, Consilium Medicum2021<p><strong>Aim. </strong>Conduct a comparative assessment of the main indicators of the incidence of cervical cancer in Khabarovsk Krai (20092019) аnd the prevalence of types of human papillomavirus among the female population.</p>
<p><strong>Materials and methods. </strong>A comparative analysis of the data of the official statistics of the Ministry of Health of Khabarovsk Krai, using the Rosstat database for the period 20092019, taking into account the incidence, mortality, prevalence of types of human papillomavirus, was carried out. The dynamics trend was determined in the process of graphical analysis of the diagram and by modeling trends. The results of the studies were subjected to the methods of statistical information processing.</p>
<p><strong>Results. </strong>The results revealed in our study indicate that the increase in the incidence of cervical cancer in Khabarovsk Krai from 2009 to 2019 was 44.4% (with an average annual growth rate of 4.5%). Most often, cervical cancer in Khabarovsk Krai is detected in urban residents. The share of urban women with this pathology in 2019 reached 77.2%. The proportion of stage III cancer detected exceeds the proportion of stage IIIIV cancer by 2.5 times. Mortality in patients with cervical cancer in Khabarovsk Krai exceeds that in the Russian Federation. Of the 1617 residents of the city of Khabarovsk of reproductive age, 883 (54%) women had the presence of human papillomavirus. For our region, most often, women had highly oncogenic types of human papillomavirus 16, 56, 51.</p>
<p><strong>Conclusion. </strong>Statistical analysis based on the results of diagnosing early and advanced stages of cervical cancer, mortality from this nosological form, and the spread of the human papillomavirus remain among the most important criteria. The data obtained make it possible to assess the effectiveness of the chosen tactics in the regions and take timely corrective measures aimed at both early detection of cervical cancer and a decrease in the persistence of the human papillomavirus in women with background cervical pathology.</p>cervical cancermortalityhuman papillomavirusрак шейки маткилетальностьвирус папилломы человека[Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term abcolut risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010; 102 (19): 1478–88.][Rodríguez AC, Schiffman M, Herrero R, et al. Longitudinal study of humanpapillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role ofduration of infection. J Natl Cancer Inst. 2010; 102 (5): 315–24.][Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки. Клинические рекомендации. Российское общество акушеров-гинекологов (РОАГ). Общероссийская общественная организация «Российское общество специалистов по профилактике и лечению опухолей репродуктивной системы» (РОСОРС). Одобрено Научно-практическим Советом Минздрава РФ. М., 2020 [Cervical intraepithelial neoplasia, erosion and ectropion of the cervix. Clinical guidelines. Russian Society of Obstetricians and Gynecologists (ROAG). All-Russian public organization “Russian Society of Specialists in the Prevention and Treatment of Tumors of the Reproductive System” (ROSORS). Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Moscow, 2020 (in Russian)].][Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55 (2): 74–108.][Презентация Глобальной стратегии по ускорению элиминации рака шейки матки. Режим доступа: https://www.who.int/ru/news-room/events/detail/2020/11/17/default-calendar/launch-of-the-global-strategy-to-accelerate-the-elimination-of-cervical-cancer. Ссылка активна на 17.11.2020 [Presentation of the Global Strategy to Accelerate the Elimination of Cervical Cancer. Available at: https: //www.who.int/ru/news-room/events/detail/2020/11/17/default-calendar/launch-of-the-global-strategy-to-accelerate-the-elimination-of-cervical-cancer. Accessed: 17.11.2020 (in Russian)].][Состояние онкологической помощи населению России в 2019 году. Под ред. Каприна А.Д., Старинского В.В., Шахзадовой А.О. М., 2020 [The state of cancer care to the population of Russia in 2019. Ed. Kaprin AD, Starinsky VV, Shahzadova AO. Moscow, 2020 (in Russian)].][Смирнова М.П., Хаджимба А.С., Максимов С.Я., Самедзаде Г.С. Особенности клинического течения ВИЧ-ассоциированного рака шейки матки. Практическая онкология. 2020; 21 (2): 131–5 [Smirnova MP, Khadzhimba AS, Maksimov SYa, Samedzadeh GS. Features of the clinical course of HIV-associated cervical cancer. Practical Oncology. 2020; 21 (2): 131–5 (in Russian)].][Состояние онкологической помощи населению России в 2018 году. Под ред. Каприна А.Д., Старинского В.В., Петровой Г.В. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2019 [The state of cancer care for the population of Russia in 2018. Ed. Kaprin AD, Starinsky VV, Petrova GV. Moscow: MNIOI PA. Herzen branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2019 (in Russian)].][Приказ Минздрава России от 15.11.2012 №915н (ред. от 05.02.2019) «Об утверждении Порядка оказания медицинской помощи населению по профилю онкология (зарегистрировано в Минюсте России 17.04.2013 №28163)». Режим доступа: https://sudact.ru/law/prikaz-minzdrava-rossii-ot-15112012-n-915n/. Ссылка активна на 17.11.2020 [Order of the Ministry of Health of Russia of 15.11.2012 No. 915n (as amended on 05.02.2019) “On approval of the Procedure for providing medical care to the population in the field of oncology” (Registered in the Ministry of Justice of Russia on 17.04.2013 No. 28163). Available at: https://sudact.ru/law/prikaz-minzdrava-rossii-ot-15112012-n-915n/. Accessed: 17.11.2020 (in Russian)].][О Программе государственных гарантий бесплатного оказания гражданам медицинской помощи на 2020 год и на плановый период 2021 и 2022 годов (с изменениями на 5 июня 2020 года). Режим доступа: http://docs.cntd.ru/document/564041496. Ссылка активна на 17.11.2020 [On the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2020 and for the Planning Period of 2021 and 2022 (as amended on June 5, 2020). Available at: http://docs.cntd.ru/document/564041496. Accessed: 17.11.2020 (in Russian)].][Профилактика рака шейки матки: Руководство для врачей. Под ред. Сухих Г.Т., Прилепской В.Н. М.: МЕДпресс-информ, 2012 [Prevention of cervical cancer: A guide for doctors. Ed. Sukhikh GT, Prilepskaya VN. Moscow: MEDpress-inform, 2012 (in Russian)].][Заболевания шейки матки и генитальные инфекции. Под ред. проф. Прилепской В.Н. М.: ГЭОТАР-Медиа, 2016 [Diseases of the cervix and genital infections. Ed. prof. Prilepskaya VN. Moscow: GEOTAR-Media, 2016 (in Russian)].][Донников А.Е., Маркелов М.И., Пестрикова Т.Ю., и др. Анализ распространенности и вирусной нагрузки различных типов вируса папилломы человека в регионах Российской Федерации. Акушерство и гинекология. 2019; 4: 39–47 [Donnikov AE, Markelov MI, Pestrikova TYu, et al. Analysis of the prevalence and viral load of various types of human papillomavirus in the regions of the Russian Federation. Obstetrics and gynecology. 2019; 4: 39–47 (in Russian)].][Пестрикова Т.Ю., Юрасова Е.А., Панфилова Ю.О., Шматкова А.С. Новый подход к лечению рецидивирующего хронического цервицита, ассоциированного с ВПЧ-инфекцией, с помощью локальной цитокинотерапии. Вопр. гинекологии, акушерства и перинатологии. 2019; 18 (4): 19–27 [Pestrikova TYu, Yurasova EA, Panfilova YuO, Shmatkova AS. A new approach to the treatment of recurrent chronic cervicitis associated with HPV infection using local cytokine therapy. Questions of gynecology, obstetrics and perinatology. 2019; 18 (4): 19–27 (in Russian)].][Мальцева Л.И., Фаррахова ЛН. Возможности терапии ВПЧ-ассоциированного хронического цервицита у женщин. Акушерство и гинекология. 2017; 6: 127–34 [Maltseva LI, Farrakhova LN. Possibilities of therapy for HPV-associated chronic cervicitis in women . Obstetrics and gynecology. 2017; 6: 127–34 (in Russian)].][Пестрикова Т.Ю., Пушкарь В.А. Оценка эффективности комплексной терапии патологии шейки матки, ассоциированной с папилломавирусной инфекцией. Гинекология. 2015; 17 (4): 50–3 [Pestrikova TYu, Pushkar VA. Evaluation of the effectiveness of complex therapy of cervical pathology associated with human papillomavirus infection. Gynecology. 2015; 17 (4): 50–3 (in Russian)].][Jakobsson M, Pukkala E, Paavonen J, et al. Cancer incidence among Finnish women with surgical treatment for cervical intraepithelial neoplasia, 1987–2006. Int J Cancer. 2011; 128 (5): 1187–91.][Shen XH, Liu SH. Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Hangzhou, China. Asian Pac J Cancer Prev. 2013; 14 (6): 3603–6.]